Treatment of pulmonary fibrosis. New substances and new interventions;Therapie der lungenfibrose: Neue substanzen, neue interventionen

Internist

Volumn 52, Issue 12, 2011, Pages 1422-1428

  Costabel, U ^a   Bonella, F ^a  

^a RUHRLANDKLINIK   (Germany)

Author keywords

Antifibrotic therapy; Fibroblasts; Idiopathic pulmonary fibrosis; N acetylcysteine; Pirfenidone

Indexed keywords

ACETYLCYSTEINE; AMBRISENTAN; AZATHIOPRINE; BOSENTAN; ETANERCEPT; GAMMA INTERFERON; IMATINIB; PIRFENIDONE; PLACEBO; PREDNISONE; SILDENAFIL;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG APPROVAL; DRUG EFFECT; EUROPEAN UNION; GASTROINTESTINAL SYMPTOM; HUMAN; IDIOPATHIC DISEASE; INTERVENTION STUDY; LUNG FIBROSIS; LUNG FUNCTION; MULTICENTER STUDY; PHOTOSENSITIVITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; HUMANS; PULMONARY FIBROSIS;

EID: 84857193501     PISSN: 00209554     EISSN: 14321289     Source Type: Journal    
DOI: 10.1007/s00108-011-2926-0     Document Type: Article

References (30)

1. Azuma A, Nukiwa T, Tsuboi e et al (2005) Doubleblind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 171:1040-1047 (Pubitemid 40616955)
2. Bargagli E, Olivieri C, Bennett D et al (2009) Oxidative stress in the pathogenesis of diffuse lung diseases: a review. Respir Med 103:1245-1256
3. Behr J, Demedts M, Buhl R et al (2009) Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial. Respir Res 10:101
4. Bradley B, Branley HM, Egan JJ et al (2008) Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63(Suppl 5):v1-v58
5. Costabel U (2011) Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients? Eur Respir Rev 20:201-207
6. Daniels CE, Lasky JA, Limper AH et al (2010) Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. Am J Respir Crit Care Med 181:604-610
7. Demedts M, Behr J, Buhl R et al (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229-2242 (Pubitemid 41697286)
8. Du Bois RM, Weycker D, Albera C et al (2011) Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184:459-466
9. Egan JJ (2011) Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient. Eur Respir Rev 20:114-117
10. Johnson MA, Kwan S, Snell NJ et al (1989) Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 44:280-288 (Pubitemid 19113529)
11. King TE, Albera C, Bradford WZ et al (2009) Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 374:222-228
12. King TE, Behr J, Brown KK et al (2008) BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177:75-81
13. King TE, Brown KK, Raghu G et al (2011) BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184:92-99
14. Lee JS, Mclaughlin S, Collard HR (2011) Comprehensive care of the patient with idiopathic pulmonary fibrosis. Curr Opin Pulm Med 17:348-354
15. Liu RM, Gaston Pravia KA (2010) Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med 48:1-15
16. Meyer A, Buhl R, Magnussen H (1994) The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 7:431-436 (Pubitemid 24099000)
17. Navaratnam V, Fleming KM, West J et al (2011) The rising incidence of idiopathic pulmonary fibrosis in the U. K. Thorax 66:462-467
18. Noble PW, Albera C, Bradford WZ et al (2011) Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377:1760-1769
19. Oku H, Shimizu T, Kawabata T et al (2008) Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 590:400-408
20. Olson AL, Swigris JJ, Lezotte DC et al (2007) Mortality from pulmonary fibrosis increased in the United States from 1992-2003. Am J Respir Crit Care Med 176:277-284 (Pubitemid 47195878)
21. Raghu G, Brown KK, Costabel U et al (2008) Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 178:948-955
22. Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788-824
23. Raghu G, Depaso WJ, Cain K et al (1991) Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 144:291-296
24. Richeldi L, Costabel U, Selman M et al (2011) Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365:1079-1087
25. Schaefer CJ, Ruhrmund DW, Pan L et al (2011) Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev 20:85-97
26. Selman M, Pardo A (2006) Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 3:364-372 (Pubitemid 43845414)
27. Spagnolo P, Del Giovane C, Luppi F et al (2010) Non-steroid agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 9: CD003134
28. Taniguchi H, Ebina M, Kondoh y et al (2010) Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35:821-829
29. Vancheri C, Failla M, Crimi N et al (2010) Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 35:496-504
30. Zisman DA, Schwarz M, Anstrom KJ et al (2010) A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 363:620-628